electroCore, Inc.
NASDAQ:ECORMedical - Devices
-$0.50 today
- Market cap
- $71.13M
- Beta
- 0.87
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.72
Volume 0.06M
Average 0.11M
ECOR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
electroCore, Inc.NASDAQ: ECOR
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $740K rose 15.3% year over year, ahead of the +8.8% change in trailing-twelve-month research & development. Sequentially, it fell 19.6% from the prior quarter. Over 3 fiscal years it compounded at -20.9% a year.
Context
- Research & development amounted to 8.5% of revenue in FY2025, down 0.8 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +15.3% holds above the trailing-twelve-month pace of +8.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 2.74M USD
- Year-over-year change
- +15.9%
- 4-year CAGR
- +1.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.74M | +15.9% |
| FY2024 | 2024-12-31 | 2.36M | -55.6% |
| FY2023 | 2023-12-31 | 5.32M | -3.6% |
| FY2022 | 2022-12-31 | 5.52M | +117.7% |
| FY2021 | 2021-12-31 | 2.54M | — |
Research & Development vs competitors
How ECOR compares with its peers on the latest reported figures
- ECOR's LTM Mar 2026 research & development of $2.83M is the 5th highest of the 6 companies compared; the peer median is $6.78M.
- Its year-over-year change of +8.8% is the 3rd highest of 6, against a peer median of -1.8%.
- Research & development amounts to 8.1% of revenue for ECOR, versus a peer median of 64.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $23.45M | -1.8% | -5.3% | — | |
| LTM Mar 2026 | $14.87M | +36.6% | +1076.5% | — | |
| LTM Mar 2026 | $6.78M | +20.9% | +40.9% | 16.4% | |
| LTM Mar 2026 | $5.84M | -8.9% | +13.4% | 392.2% | |
| LTM Mar 2026 | $2.83M | +8.8% | -20.9% | 8.1% | |
| LTM Jun 2026 | $908.07K | -86.6% | -47.7% | 64.8% | |
| Peer median (excluding ECOR) | $6.78M | -1.8% | +13.4% | 64.8% | |
Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.45M | 8.59M | 16.03M | 25.18M | 32.03M |
| Cost of Revenue | 1.39M | 1.62M | 2.8M | 3.79M | 4.24M |
| Gross Profit | 4.07M | 6.98M | 13.23M | 21.4M | 27.79M |
| Gross Margin | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% |
| Research & Development | 2.54M | 5.52M | 5.32M | 2.36M | 2.74M |
| Selling, General & Admin | 21.57M | 24.33M | 26.71M | 31.2M | 38.21M |
| Operating Expenses | 24.11M | 29.85M | 32.03M | 33.56M | 40.94M |
| Depreciation & Amortization | 382K | 596K | 1.26M | 1.26M | 1.68M |
| EBITDA | (17.69M) | (22M) | (17.76M) | (10.72M) | (11.7M) |
| EBITDA Margin | -324.5% | -256.0% | -110.8% | -42.6% | -36.5% |
| Operating Income | (20.04M) | (22.87M) | (18.81M) | (12.16M) | (13.15M) |
| Operating Margin | -367.7% | -266.2% | -117.3% | -48.3% | -41.1% |
| Interest Income | 11K | 287K | 433K | 572K | 298K |
| Interest Expense | 0 | 0 | 0 | 0 | 590K |
| Other Income / Expenses | 1.97M | 281K | (215K) | 183K | (810K) |
| Income Before Tax | (18.07M) | (22.59M) | (19.02M) | (11.98M) | (13.96M) |
| Pre-Tax Margin | -331.5% | -263.0% | -118.7% | -47.6% | -43.6% |
| Income Tax Expense | (851K) | (431K) | (186K) | (93K) | 3K |
| Net Income | (17.22M) | (22.16M) | (18.83M) | (11.89M) | (13.97M) |
| Net Margin | -315.9% | -257.9% | -117.5% | -47.2% | -43.6% |
| EPS (Basic) | (4.36) | (4.69) | (3.42) | (1.59) | (1.65) |
| EPS (Diluted) | (4.36) | (4.69) | (3.42) | (1.59) | (1.65) |
| Weighted Avg Shares | 3.95M | 4.73M | 5.52M | 7.48M | 8.48M |
| Weighted Avg Shares (Diluted) | 3.95M | 4.73M | 5.52M | 7.48M | 8.48M |
electroCore, Inc.
NASDAQ:ECOR
Intrinsic Alpha fair value
Locked
Current Price
$7.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.